MicroRNAs as Therapeutic Targets and Biomarkers of Cardiovascular Disease

MicroRNAs play central roles in cardiovascular disease, and their therapeutic manipulation raises exciting opportunities as well as challenges in the path toward clinical development. MicroRNAs play central roles in cardiovascular disease, and their therapeutic manipulation raises exciting opportunities as well as challenges in the path toward clinical development.

[1]  W. Pu,et al.  Strategies for Cardiac Regeneration and Repair , 2014, Science Translational Medicine.

[2]  P. Doevendans,et al.  Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart , 2014, Nature.

[3]  F. Kiessling,et al.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 , 2014, Nature Medicine.

[4]  L. Windt,et al.  Cardiovascular extracellular microRNAs: emerging diagnostic markers and mechanisms of cell-to-cell RNA communication , 2013, Front. Genet..

[5]  M. Fabbri,et al.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.

[6]  S. Heymans,et al.  Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure , 2013, Nature Cell Biology.

[7]  Tara M. Holmes,et al.  Atrial natriuretic peptide is negatively regulated by microRNA-425. , 2013, The Journal of clinical investigation.

[8]  G. Wang,et al.  mir-17–92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts , 2013, Circulation research.

[9]  L. Zentilin,et al.  Functional screening identifies miRNAs inducing cardiac regeneration , 2012, Nature.

[10]  G. Dorn,et al.  A Human 3′ miR-499 Mutation Alters Cardiac mRNA Targeting and Function , 2012, Circulation research.

[11]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[12]  Achilleas S. Frangakis,et al.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs , 2012, Nature Cell Biology.

[13]  A. Tijsen,et al.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? , 2012, Circulation research.

[14]  E. van Rooij,et al.  Developing microRNA therapeutics. , 2012, Circulation research.

[15]  M. Vinciguerra,et al.  MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation , 2011, Circulation research.

[16]  G. Dorn,et al.  miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes , 2011, Circulation research.

[17]  E. Olson,et al.  Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters , 2011, Proceedings of the National Academy of Sciences.

[18]  E. Olson,et al.  Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.

[19]  S. Kauppinen,et al.  Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.

[20]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[21]  E. Olson,et al.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.

[22]  David G Hendrickson,et al.  Concordant Regulation of Translation and mRNA Abundance for Hundreds of Targets of a Human microRNA , 2009, PLoS biology.

[23]  D. Srivastava,et al.  MicroRNA regulation of cardiovascular development. , 2009, Circulation research.

[24]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[25]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[26]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[27]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[28]  F. Kiessling,et al.  MicroRNA-1265 p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk 1 , 2015 .

[29]  S. Dimmeler,et al.  Vascular microRNAs. , 2010, Current drug targets.